Satiereal
Best for
Stay asleep through the night
Likely benefit for 5–6 weeks · 1 meta-analysis , n=292
44 papers · 10 claims · 109 outcomes scored · 8 positive
Outcomes
What satiereal actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Fewer wake-ups and more unbroken hours of real rest.
The background hum of worry that colors everything gets quieter.
Quiets the health worries and body tension that build with age.
Quiets the overthinking that hijacks execution right before you compete.
Everyday pressure stops running your nervous system hot.
Lowers the weight of sadness, low energy, and emotional numbness over weeks.
Compensates for the sunlight deficit when days get short.
When pain loosens its grip, mood follows.
Fewer days where health problems dictate what you can and cannot do.
Lower intensity, fewer flares, and longer stretches of relief.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Stay asleep through the night Likely benefit | | 2 meta-analyses n=292 Meta-analyzed | 0.6–300 mg | 5–6 wk | #2/15 |
| Lower day-to-day anxiety Faint early signal | | 3 meta-analyses n=191 Meta-analyzed | 0.6–300 mg | 1–5 wk | #9/48 |
| Ease anxiety in older adults Faint early signal | | 3 meta-analyses n=191 Meta-analyzed | 0.6–300 mg | 1–5 wk | #9/45 |
| Reduce pre-competition anxiety Faint early signal | | 3 meta-analyses n=191 Meta-analyzed | 0.6–300 mg | 1–5 wk | #9/45 |
| Reduce daily stress Faint early signal | | 2 RCTs n=19 | 0.06–30 mg | 8 wk | — |
| Ease depression symptoms Proven but unnoticeable | | 9 meta-analyses n=18k Meta-analyzed | 0.6–300 mg | 4–48 wk | #2/41 |
| Ease winter depression symptoms Proven but unnoticeable | | 8 meta-analyses n=18k Meta-analyzed | 15–125 mg | 4–48 wk | #2/39 |
| Ease depression tied to chronic pain Proven but unnoticeable | | 8 meta-analyses n=18k Meta-analyzed | 15–125 mg | 4–48 wk | #2/39 |
| Improve everyday quality of life Not enough research | | 1 RCT n=— | 15.5 mg | 6 wk | — |
| Reduce everyday pain intensity Not enough research | | 1 meta-analysis n=— Meta-analyzed | 100 mg | 12 wk | #10/55 |
Recommended Satiereal products
Real products that dose Satiereal where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
SuperSmart
Weight Loss Booster
Well dosed 176.5 mg/day A formulaBrand audit 63/100
-
The Genius Brand
Genius Diet Pills
Well dosed 176.5 mg/day A formula
Chosen for adequate Satiereal dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Sources
- 1. Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis. (2022) ↑
- 2. Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial. (2021) ↑
- 3. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. (2012) ↑
- 4. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. (2013) ↑
- 5. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. (2013) ↑
- 6. Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials. (2018) ↑
- 7. The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: a systematic review and meta-analysis. (2019) ↑
- 8. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. (2020) ↑
- 9. Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial. (2020) ↑
- 10. Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis. (2025) ↑
Generated August 14, 2026
Related